Published in Biophys Chem on April 01, 1993
Urea unfolding of peptide helices as a model for interpreting protein unfolding. Proc Natl Acad Sci U S A (1995) 2.01
Thermodynamics of interactions of urea and guanidinium salts with protein surface: relationship between solute effects on protein processes and changes in water-accessible surface area. Protein Sci (2001) 1.69
Anion binding to the ubiquitin molecule. Protein Sci (1998) 1.40
Molecular modeling of the RNA binding N-terminal part of cowpea chlorotic mottle virus coat protein in solution with phosphate ions. Biophys J (1996) 0.86
New evidence for the denaturant binding model. Protein Sci (1999) 0.84
Urea-induced dissociation and unfolding of dodecameric glutamine synthetase from Escherichia coli: calorimetric and spectral studies. Protein Sci (1995) 0.83
High-resolution molecular discrimination by RNA. Science (1994) 5.33
Nuclease-resistant nucleic acid ligands to vascular permeability factor/vascular endothelial growth factor. Chem Biol (1995) 1.75
Modified RNA sequence pools for in vitro selection. Nucleic Acids Res (1994) 1.72
Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor in glomerulonephritis by aptamers. Am J Pathol (1999) 1.42
Detection and plasma pharmacokinetics of an anti-vascular endothelial growth factor oligonucleotide-aptamer (NX1838) in rhesus monkeys. J Chromatogr B Biomed Sci Appl (1999) 1.29
Interactions of Escherichia coli RNA with bacteriophage MS2 coat protein: genomic SELEX. Nucleic Acids Res (2000) 1.19
Physical properties of the Escherichia coli transcription termination factor rho. 1. Association states and geometry of the rho hexamer. Biochemistry (1992) 1.18
Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys. Pharm Res (2000) 1.14
Liposome-anchored vascular endothelial growth factor aptamers. Bioconjug Chem (1998) 1.12
Antitumor efficacy, pharmacokinetics, and biodistribution of NX 211: a low-clearance liposomal formulation of lurtotecan. Clin Cancer Res (2000) 0.87
High-affinity aptamers selectively inhibit human nonpancreatic secretory phospholipase A2 (hnps-PLA2). J Med Chem (1998) 0.84
Peptide-urea interactions as observed in diketopiperazine-urea cocrystal. Biophys Chem (1993) 0.81
The solubilities of five cyclic dipeptides in water and in aqueous urea at 298.15 K: a quantitative model for the denaturation of proteins in aqueous urea solutions. Biophys Chem (1994) 0.75